arrow_back Back to App

Ban on Funding Research Enhancing Pandemic Pathogens Until 2026

This act temporarily prohibits the National Institutes of Health (NIH) from funding or conducting research that could increase the infectivity or pathogenicity of influenza viruses and coronaviruses in mammals. This aims to reduce risks associated with potentially dangerous pathogen experiments.
Key points
NIH is prohibited from funding or conducting research that enhances the infectivity or pathogenicity of influenza viruses and coronaviruses.
The prohibition is in effect until September 30, 2026.
The ban does not apply to studying naturally occurring viruses unless the study is intended to increase their infectivity or pathogenicity.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5270
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Process start date: 2021-09-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Pausing Enhanced Pandemic Pathogen Research Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5270.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-09-17.

What are the main provisions?

Key points include:

  • NIH is prohibited from funding or conducting research that enhances the infectivity or pathogenicity of influenza viruses and coronaviruses.
  • The prohibition is in effect until September 30, 2026.
  • The ban does not apply to studying naturally occurring viruses unless the study is intended to increase their infectivity or pathogenicity.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Carter, Earl L. "Buddy" [R-GA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health